ABBV

2024Q2BMO

AbbVie Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2024-07-25 · Fiscal end 2024-06-30 · Features as of 2024-07-24

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS2.66
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move1.4%
IV front—
P/C full—
P/C front—
Features as of2024-07-24

Run-up

Close—
Ret 5d+0.5%
Ret 10d+4.8%
Ret 20d+3.2%
Ret 30d+3.4%

Post-Earnings Data

Results & reaction

Print

Actual EPS
2.65Miss
Estimated EPS2.66
Actual revenue
14.5B
Surprise %-0.4%
Beat / missMiss
Beat streak 40
Beat streak 80

Reaction

1-day stock reaction+2.9%
Implied vs actual

Implied 1.4%Actual 0.4%

Gap reaction+0.4%
Day result+3.4%
Next-day upYes
Realized / IV0.32×

Post tape

Post 5d+4.1%
Post 10d+4.5%
Post volume9.4M
Vol ×10d2.13×
Vol ×20d1.68×
Post range8.1%